annual SGA:
$280.32M+$96.06M(+52.13%)Summary
- As of today (May 21, 2025), CORT annual SGA is $280.32 million, with the most recent change of +$96.06 million (+52.13%) on December 31, 2024.
- During the last 3 years, CORT annual SGA has risen by +$157.96 million (+129.10%).
- CORT annual SGA is now at all-time high.
Performance
CORT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$90.66M+$7.29M(+8.74%)Summary
- As of today (May 21, 2025), CORT quarterly SGA is $90.66 million, with the most recent change of +$7.29 million (+8.74%) on March 31, 2025.
- Over the past year, CORT quarterly SGA has increased by +$34.39 million (+61.12%).
- CORT quarterly SGA is now at all-time high.
Performance
CORT quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$2.09B+$133.99M(+6.86%)Summary
- As of today (May 21, 2025), CORT TTM SGA is $2.09 billion, with the most recent change of +$133.99 million (+6.86%) on March 31, 2025.
- Over the past year, CORT TTM SGA has increased by +$1.89 billion (+987.08%).
- CORT TTM SGA is now at all-time high.
Performance
CORT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CORT Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +52.1% | +61.1% | +987.1% |
3 y3 years | +129.1% | +141.4% | +1500.3% |
5 y5 years | +179.3% | +229.3% | +1916.2% |
CORT Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +129.1% | at high | +157.8% | at high | +194.7% |
5 y | 5-year | at high | +179.3% | at high | +254.5% | at high | +1498.1% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | +257.7% |
CORT Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $90.66M(+8.7%) | $314.71M(+12.3%) |
Dec 2024 | $280.32M(+52.1%) | $83.37M(+13.1%) | $280.32M(+14.8%) |
Sep 2024 | - | $73.75M(+10.2%) | $244.10M(+13.2%) |
Jun 2024 | - | $66.94M(+19.0%) | $215.62M(+12.3%) |
Mar 2024 | - | $56.27M(+19.3%) | $191.96M(+4.2%) |
Dec 2023 | $184.26M(+20.6%) | $47.15M(+4.2%) | $184.26M(+2.7%) |
Sep 2023 | - | $45.26M(+4.6%) | $179.43M(+6.0%) |
Jun 2023 | - | $43.28M(-10.9%) | $169.33M(+3.3%) |
Mar 2023 | - | $48.56M(+14.7%) | $163.86M(+7.2%) |
Dec 2022 | $152.85M(+24.9%) | $42.32M(+20.4%) | $152.85M(+7.0%) |
Sep 2022 | - | $35.16M(-7.0%) | $142.81M(+3.4%) |
Jun 2022 | - | $37.81M(+0.7%) | $138.18M(+6.0%) |
Mar 2022 | - | $37.55M(+16.3%) | $130.40M(+6.6%) |
Dec 2021 | $122.36M(+16.2%) | $32.28M(+5.7%) | $122.36M(+5.7%) |
Sep 2021 | - | $30.53M(+1.7%) | $115.77M(+3.6%) |
Jun 2021 | - | $30.03M(+1.8%) | $111.76M(+4.2%) |
Mar 2021 | - | $29.51M(+14.8%) | $107.30M(+1.9%) |
Dec 2020 | $105.33M(+4.9%) | $25.70M(-3.1%) | $105.33M(-1.3%) |
Sep 2020 | - | $26.52M(+3.7%) | $106.76M(+2.2%) |
Jun 2020 | - | $25.57M(-7.1%) | $104.48M(+0.9%) |
Mar 2020 | - | $27.54M(+1.5%) | $103.50M(+3.1%) |
Dec 2019 | $100.36M(+23.5%) | $27.13M(+11.9%) | $100.36M(+5.9%) |
Sep 2019 | - | $24.25M(-1.4%) | $94.78M(+3.2%) |
Jun 2019 | - | $24.59M(+0.8%) | $91.85M(+5.3%) |
Mar 2019 | - | $24.39M(+13.1%) | $87.24M(+7.3%) |
Dec 2018 | $81.29M(+30.2%) | $21.56M(+1.2%) | $81.29M(+6.2%) |
Sep 2018 | - | $21.31M(+6.6%) | $76.52M(+6.7%) |
Jun 2018 | - | $19.98M(+8.4%) | $71.69M(+8.9%) |
Mar 2018 | - | $18.44M(+9.8%) | $65.82M(+5.5%) |
Dec 2017 | $62.42M(+38.0%) | $16.80M(+2.0%) | $62.42M(+8.8%) |
Sep 2017 | - | $16.47M(+16.7%) | $57.38M(+10.7%) |
Jun 2017 | - | $14.11M(-6.1%) | $51.84M(+4.0%) |
Mar 2017 | - | $15.04M(+27.9%) | $49.85M(+10.2%) |
Dec 2016 | $45.24M(+22.4%) | $11.76M(+7.6%) | $45.24M(+6.8%) |
Sep 2016 | - | $10.93M(-9.8%) | $42.34M(+4.0%) |
Jun 2016 | - | $12.12M(+16.2%) | $40.70M(+7.3%) |
Mar 2016 | - | $10.43M(+17.7%) | $37.93M(+2.6%) |
Dec 2015 | $36.95M(+5.8%) | $8.86M(-4.6%) | $36.95M(+2.3%) |
Sep 2015 | - | $9.29M(-0.5%) | $36.13M(+0.5%) |
Jun 2015 | - | $9.34M(-1.2%) | $35.94M(+4.0%) |
Mar 2015 | - | $9.45M(+17.5%) | $34.56M(-1.0%) |
Dec 2014 | $34.92M(+11.8%) | $8.04M(-11.6%) | $34.92M(+1.5%) |
Sep 2014 | - | $9.10M(+14.3%) | $34.39M(+5.9%) |
Jun 2014 | - | $7.96M(-18.8%) | $32.47M(-0.6%) |
Mar 2014 | - | $9.80M(+30.4%) | $32.66M(+4.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2013 | $31.24M(+22.9%) | $7.52M(+4.7%) | $31.24M(+3.4%) |
Sep 2013 | - | $7.18M(-12.0%) | $30.20M(+5.2%) |
Jun 2013 | - | $8.16M(-2.7%) | $28.72M(+9.2%) |
Mar 2013 | - | $8.38M(+29.3%) | $26.31M(+3.5%) |
Dec 2012 | $25.41M(+124.3%) | $6.48M(+13.8%) | $25.41M(+14.4%) |
Sep 2012 | - | $5.69M(-1.0%) | $22.21M(+12.6%) |
Jun 2012 | - | $5.75M(-23.2%) | $19.73M(+18.5%) |
Mar 2012 | - | $7.49M(+128.1%) | $16.64M(+46.9%) |
Dec 2011 | $11.33M(+33.5%) | $3.28M(+2.3%) | $11.33M(+1.1%) |
Sep 2011 | - | $3.21M(+20.4%) | $11.21M(+13.4%) |
Jun 2011 | - | $2.67M(+22.6%) | $9.88M(+8.7%) |
Mar 2011 | - | $2.17M(-31.2%) | $9.09M(+7.1%) |
Dec 2010 | $8.49M(+44.4%) | $3.16M(+68.0%) | $8.49M(+25.9%) |
Sep 2010 | - | $1.88M(+0.5%) | $6.74M(+5.3%) |
Jun 2010 | - | $1.87M(+18.8%) | $6.40M(+5.3%) |
Mar 2010 | - | $1.57M(+11.4%) | $6.08M(+3.4%) |
Dec 2009 | $5.88M(+2.3%) | $1.41M(-8.4%) | $5.88M(-0.3%) |
Sep 2009 | - | $1.54M(-0.2%) | $5.90M(-2.1%) |
Jun 2009 | - | $1.55M(+12.5%) | $6.02M(+2.3%) |
Mar 2009 | - | $1.37M(-4.2%) | $5.89M(+2.5%) |
Dec 2008 | $5.75M(+18.1%) | $1.43M(-14.0%) | $5.75M(-5.2%) |
Sep 2008 | - | $1.67M(+18.3%) | $6.06M(+8.5%) |
Jun 2008 | - | $1.41M(+14.4%) | $5.58M(+12.4%) |
Mar 2008 | - | $1.23M(-29.4%) | $4.96M(+2.0%) |
Dec 2007 | $4.87M(-3.5%) | $1.75M(+46.6%) | $4.87M(+14.2%) |
Sep 2007 | - | $1.19M(+50.3%) | $4.26M(-4.7%) |
Jun 2007 | - | $793.00K(-30.1%) | $4.47M(-8.0%) |
Mar 2007 | - | $1.14M(-0.6%) | $4.86M(-3.6%) |
Dec 2006 | $5.04M(+23.5%) | $1.14M(-18.5%) | $5.04M(+3.1%) |
Sep 2006 | - | $1.40M(+18.6%) | $4.89M(+9.9%) |
Jun 2006 | - | $1.18M(-10.2%) | $4.45M(+2.8%) |
Mar 2006 | - | $1.32M(+32.8%) | $4.33M(+5.9%) |
Dec 2005 | $4.08M(-9.1%) | $991.00K(+3.2%) | $4.08M(-5.2%) |
Sep 2005 | - | $960.00K(-9.5%) | $4.31M(-4.4%) |
Jun 2005 | - | $1.06M(-1.1%) | $4.51M(-1.4%) |
Mar 2005 | - | $1.07M(-11.8%) | $4.57M(+1.8%) |
Dec 2004 | $4.49M(-18.7%) | $1.22M(+4.8%) | $4.49M(+37.1%) |
Sep 2004 | - | $1.16M(+3.1%) | $3.28M(+20.0%) |
Jun 2004 | - | $1.13M(+13.3%) | $2.73M(+23.0%) |
Mar 2004 | - | $993.00K(+61.8%) | $2.22M(+43.6%) |
Sep 2003 | - | $613.90K(-0.1%) | $1.55M(+65.8%) |
Jun 2003 | - | $614.60K(+92.7%) | $933.50K(+192.7%) |
Mar 2003 | - | $318.90K | $318.90K |
Dec 2002 | $5.53M(+111.4%) | - | - |
Dec 2001 | $2.62M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual SGA?
- What is the all time high annual SGA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual SGA year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly SGA?
- What is the all time high quarterly SGA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly SGA year-on-year change?
- What is Corcept Therapeutics Incorporated TTM SGA?
- What is the all time high TTM SGA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM SGA year-on-year change?
What is Corcept Therapeutics Incorporated annual SGA?
The current annual SGA of CORT is $280.32M
What is the all time high annual SGA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual SGA is $280.32M
What is Corcept Therapeutics Incorporated annual SGA year-on-year change?
Over the past year, CORT annual SGA has changed by +$96.06M (+52.13%)
What is Corcept Therapeutics Incorporated quarterly SGA?
The current quarterly SGA of CORT is $90.66M
What is the all time high quarterly SGA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly SGA is $90.66M
What is Corcept Therapeutics Incorporated quarterly SGA year-on-year change?
Over the past year, CORT quarterly SGA has changed by +$34.39M (+61.12%)
What is Corcept Therapeutics Incorporated TTM SGA?
The current TTM SGA of CORT is $2.09B
What is the all time high TTM SGA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM SGA is $2.09B
What is Corcept Therapeutics Incorporated TTM SGA year-on-year change?
Over the past year, CORT TTM SGA has changed by +$1.89B (+987.08%)